Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 11 symbols : ABBV save search
FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukemia
Published: 2021-06-11 (Crawled : 14:04) - fda.gov
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.0%
H: 0.1%
C: -0.71%
fda granted approval leukemia myeloid leukemia grant acute myeloid leukemia
US Healthcare Contract Development and Manufacturing Organization (CDMO) Market 2021-2026: Product Launches, Mergers and Acquisitions, Collaborations with Government, and Technological Advancements
Published: 2021-06-11 (Crawled : 12:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -0.18%
H: 0.39%
C: 0.23%
JBL F | $120.24 -0.54% 0.0% 1.4M
|
Electronic Technology
|
| O: 0.72%
H: 0.62%
C: 0.24%
CTLT | $55.95 -0.14% 0.0% 2M
|
Health Technology
|
| O: 0.39%
H: 0.0%
C: -0.22%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.0%
H: 0.1%
C: -0.71%
acquisition collaboration acquisitions contract ev merge
X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021
Published: 2021-06-11 (Crawled : 08:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.0%
H: 0.1%
C: -0.71%
XFOR | $1.28 4.06% 3.91% 2.2M
|
Health Technology
|
| O: -1.8%
H: 0.97%
C: -5.51%
presentation ongoing phase 1 positive trial phase 1b phase 2b
New Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment
Published: 2021-06-11 (Crawled : 06:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.0%
H: 0.1%
C: -0.71%
treatment leukemia
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.